Page 21 - Serum Institute Of India

Top headlines: India aims to double gas pipeline; SC clears Central Vista

A FinMin report says India is witnessing a 'V-shaped' economic recovery since June; China court awards death sentence to former business executive.

Serum, Bharat Biotech announce 'combined intent' to supply vaccines

The more important task right now is of saving the lives and livelihoods of populations in India and around the world, a joint statement by both companies said

India's Covid-19 vaccination challenge needs a private sector helping hand

The media and opposition figures have justifiably asked why Bharat Biotech's candidate was approved at the same time as AstraZeneca's, when it hasn't even finished or published results from Stage III

Best of BS Opinion: Covid-19 vaccine, promise of techno-nationalism & more

Here's a selection of Business Standard opinion pieces for the day

Covid-19 vaccine: I am not worried about the efficacy, says Jacob John

I would go for Bharat Biotech's Covaxin and not Covishield, and that is my personal judgment, the former head of Centre for Advanced Research in Virology at ICMR says

Bharat Biotech chief takes on Serum Institute in Covid-19 vaccine war

Krishna Ella turns the tables on critics, questions approval granted to Oxford-Astra vaccine

A shot at transparency

Approval to Covaxin raises many questions

Covaxin: Science, not pride will help India build trust in this vaccine

The hasty nod for Bharat Biotech's Covaxin, developed in collaboration with the ICMR and National Institute of Virology, has raised eyebrows in the scientific and healthcare communities

World's biggest Covid-19 vaccination programme set to begin in India: PM

Lauding the people behind this Made in India initiative, Modi said: "The country is proud of the contributions of its scientists and technicians."

India gets Covid-19 vaccine: DCGI nod for Serum Institute, Bharat Biotech

Health Minister Harsh Vardhan termed it a 'watershed moment in India's battle against Covid-19'

Covishield to cost Rs 200/dose for first 100 mn doses to govt: Serum CEO

MRP for private market Rs 1,000/ dose; current licence does not allow export or sale in private market

Serum, Bharat Biotech vaccines get restricted use approval from DCGI

While the Oxford-AstraZeneca vaccine made by Serum Institute here has 70.42% efficacy, Bharat Biotech's still does not have efficacy data as trials are underway in India

A jab at risk: Serum's quest to lead the world in Covid-19 vaccine race

It took a chance by ramping up capacity on vaccines when they were yet to be approved and is set to emerge a global winner

Next step on vaccines

Nationwide roll-out needs meticulous planning

All risks paid off, India proud: SII, Bharat Biotech on Covid vaccine nod

With the government approving two Covid-19 vaccines for emergency use, Serum Institute said it is ready to roll out Covishield vaccine in India in the coming weeks

Congress not proud of anything Indian: Nadda over vaccine approval concerns

"Congress and the Opposition is not proud of anything Indian. They should introspect about how their lies on the Covid-19 vaccine will be used by vested interest groups for their own agendas," he said

SII will sell vaccine for Rs 200 to govt, Rs 1,000 to public: Report

He said that the vaccine will be rolled out in the next 7 to 10 days

Approval for vaccines accelerates India's journey to be Covid-free: Modi

Modi said it will make every Indian proud that both the vaccines are made in India

India approves two coronavirus vaccines for restrictive, emergency use

Drug Controller General of India (DCGI) V.G. Somani on Sunday approved Serum Institute of India's 'Covishield' vaccine and Bharat Biotech's 'Covaxin' for emergency use

Covishield moves closer to roll-out; SII gets in-principle nod from panel

India would need 30 million doses in the first phase when it vaccinates the essential services workers including health care professionals, municipal and police staff, etc